CRC (COLORECTAL CANCER)
Clinical trials for CRC (COLORECTAL CANCER) explained in plain language.
Never miss a new study
Get alerted when new CRC (COLORECTAL CANCER) trials appear
Sign up with your email to follow new studies for CRC (COLORECTAL CANCER), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune cells engineered to attack hard-to-treat colon cancer
Disease control TerminatedThis early-phase study tests a new treatment called WD-01, which uses a patient's own immune cells modified to target a protein (GCC) found on colorectal cancer cells. The goal is to see if it is safe and can shrink tumors in people with metastatic colorectal cancer who have not …
Matched conditions: CRC (COLORECTAL CANCER)
Phase: EARLY_PHASE1 • Sponsor: Wondercel Biotech (ShenZhen) • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Engineered immune cells take on advanced colon cancer
Disease control TerminatedThis early-phase study tests a new type of CAR-T cell therapy (REVO-UWD-01) for people with metastatic colorectal cancer that has spread. The treatment uses specially engineered immune cells to target a protein called GCC found on cancer cells. The main goals are to find a safe d…
Matched conditions: CRC (COLORECTAL CANCER)
Phase: EARLY_PHASE1 • Sponsor: Wondercel Biotech (ShenZhen) • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New drug combo shows promise in Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests an experimental drug called DECOY20, given alone or with another drug (tislelizumab), in about 120 adults with advanced solid tumors like liver, colorectal, pancreatic, lung, head and neck, bladder, or MSI-high cancers. The main goals are to check saf…
Matched conditions: CRC (COLORECTAL CANCER)
Phase: PHASE1, PHASE2 • Sponsor: Indaptus Therapeutics, Inc • Aim: Disease control
Last updated May 18, 2026 11:58 UTC